SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, cilt.37, sa.2, ss.135-141, 2008 (SCI-Expanded)
Objective: We analysed the production of soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 at sites of inflammation and measured their plasma concentrations to evaluate them as biological markers of disease activity.